| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |